BSECompany Update4 Aug 2026 · 4 Aug 2026, 10:43 am

As Attached

Eris Lifesciences Ltd · 540596

✦ AI SummaryResults

Eris Lifesciences Ltd has made available the transcript of its analyst and investor call following the announcement of its financial results for the quarter ended June 30, 2026, on its website.

Analysis Scores

Earnings Impact5/10

Growth Catalyst2/10

Governance Concern1/10

Regulatory Risk1/10

Balance Sheet Risk2/10

Liquidity Impact5/10

Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

Full Announcement

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Attachments (1)

📄

4759601a-79b1-4863-9ab2-854f5cb3005f.pdf

pdf

Download →

View document text

Date: 04 August 2026 To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza Dalal Street Bandra Kurla Complex Mumbai – 400001 Bandra (E) Mumbai – 400051 Security Code: 540596 Symbol: ERIS SUBJECT: TRANSCRIPT OF ANALYST AND INVESTOR CALL Dear Sir/Madam, This is to inform that the transcript of the Analyst and Investor call which was held after the announcement of financial results for the quarter ended June 30, 2026, is available on our website at URL https://eris.co.in/financials/ (File name: Q1 FY27 Earnings Call Transcript). Thanking You, For Eris Lifesciences Limited Milind Talegaonkar Company Secretary and Compliance Officer ICSI Mem. No. A26493